IBDEI0MF ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28413,1,3,0)
 ;;=3^Paroxysmal Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,28413,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,28413,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,28414,0)
 ;;=I48.1^^80^1222^21
 ;;^UTILITY(U,$J,358.3,28414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28414,1,3,0)
 ;;=3^Persistent Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,28414,1,4,0)
 ;;=4^I48.1
 ;;^UTILITY(U,$J,358.3,28414,2)
 ;;=^5007225
 ;;^UTILITY(U,$J,358.3,28415,0)
 ;;=I48.2^^80^1222^9
 ;;^UTILITY(U,$J,358.3,28415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28415,1,3,0)
 ;;=3^Chronic Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,28415,1,4,0)
 ;;=4^I48.2
 ;;^UTILITY(U,$J,358.3,28415,2)
 ;;=^5007226
 ;;^UTILITY(U,$J,358.3,28416,0)
 ;;=I48.92^^80^1222^6
 ;;^UTILITY(U,$J,358.3,28416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28416,1,3,0)
 ;;=3^Atrial Flutter,Unspec
 ;;^UTILITY(U,$J,358.3,28416,1,4,0)
 ;;=4^I48.92
 ;;^UTILITY(U,$J,358.3,28416,2)
 ;;=^5007230
 ;;^UTILITY(U,$J,358.3,28417,0)
 ;;=I48.3^^80^1222^24
 ;;^UTILITY(U,$J,358.3,28417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28417,1,3,0)
 ;;=3^Typical Atrial Flutter
 ;;^UTILITY(U,$J,358.3,28417,1,4,0)
 ;;=4^I48.3
 ;;^UTILITY(U,$J,358.3,28417,2)
 ;;=^5007227
 ;;^UTILITY(U,$J,358.3,28418,0)
 ;;=I48.4^^80^1222^7
 ;;^UTILITY(U,$J,358.3,28418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28418,1,3,0)
 ;;=3^Atypical Atrial Flutter
 ;;^UTILITY(U,$J,358.3,28418,1,4,0)
 ;;=4^I48.4
 ;;^UTILITY(U,$J,358.3,28418,2)
 ;;=^5007228
 ;;^UTILITY(U,$J,358.3,28419,0)
 ;;=Z71.89^^80^1223^1
 ;;^UTILITY(U,$J,358.3,28419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28419,1,3,0)
 ;;=3^Counseling,Other Specified
 ;;^UTILITY(U,$J,358.3,28419,1,4,0)
 ;;=4^Z71.89
 ;;^UTILITY(U,$J,358.3,28419,2)
 ;;=^5063253
 ;;^UTILITY(U,$J,358.3,28420,0)
 ;;=Z71.7^^80^1223^2
 ;;^UTILITY(U,$J,358.3,28420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28420,1,3,0)
 ;;=3^HIV Counseling
 ;;^UTILITY(U,$J,358.3,28420,1,4,0)
 ;;=4^Z71.7
 ;;^UTILITY(U,$J,358.3,28420,2)
 ;;=^5063251
 ;;^UTILITY(U,$J,358.3,28421,0)
 ;;=Z76.89^^80^1223^4
 ;;^UTILITY(U,$J,358.3,28421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28421,1,3,0)
 ;;=3^Persons Encountering Health Services for Oth Circumstances
 ;;^UTILITY(U,$J,358.3,28421,1,4,0)
 ;;=4^Z76.89
 ;;^UTILITY(U,$J,358.3,28421,2)
 ;;=^5063304
 ;;^UTILITY(U,$J,358.3,28422,0)
 ;;=Z01.812^^80^1223^3
 ;;^UTILITY(U,$J,358.3,28422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28422,1,3,0)
 ;;=3^Lab Result Counseling
 ;;^UTILITY(U,$J,358.3,28422,1,4,0)
 ;;=4^Z01.812
 ;;^UTILITY(U,$J,358.3,28422,2)
 ;;=^5062627
 ;;^UTILITY(U,$J,358.3,28423,0)
 ;;=E03.9^^80^1224^25
 ;;^UTILITY(U,$J,358.3,28423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28423,1,3,0)
 ;;=3^Hypothroidism,Unspec
 ;;^UTILITY(U,$J,358.3,28423,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,28423,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,28424,0)
 ;;=E11.9^^80^1224^22
 ;;^UTILITY(U,$J,358.3,28424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28424,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,28424,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,28424,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,28425,0)
 ;;=E10.9^^80^1224^6
 ;;^UTILITY(U,$J,358.3,28425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28425,1,3,0)
 ;;=3^DM Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,28425,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,28425,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,28426,0)
 ;;=E11.65^^80^1224^15
 ;;^UTILITY(U,$J,358.3,28426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28426,1,3,0)
 ;;=3^DM Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,28426,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,28426,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,28427,0)
 ;;=E53.8^^80^1224^30
 ;;^UTILITY(U,$J,358.3,28427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28427,1,3,0)
 ;;=3^Vitamin B Deficiency NEC
 ;;^UTILITY(U,$J,358.3,28427,1,4,0)
 ;;=4^E53.8
 ;;^UTILITY(U,$J,358.3,28427,2)
 ;;=^5002797
 ;;^UTILITY(U,$J,358.3,28428,0)
 ;;=E78.0^^80^1224^29
 ;;^UTILITY(U,$J,358.3,28428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28428,1,3,0)
 ;;=3^Pure Hypercholesterolemia
 ;;^UTILITY(U,$J,358.3,28428,1,4,0)
 ;;=4^E78.0
 ;;^UTILITY(U,$J,358.3,28428,2)
 ;;=^5002966
 ;;^UTILITY(U,$J,358.3,28429,0)
 ;;=E78.5^^80^1224^24
 ;;^UTILITY(U,$J,358.3,28429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28429,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,28429,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,28429,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,28430,0)
 ;;=E66.01^^80^1224^27
 ;;^UTILITY(U,$J,358.3,28430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28430,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,28430,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,28430,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,28431,0)
 ;;=D64.9^^80^1224^5
 ;;^UTILITY(U,$J,358.3,28431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28431,1,3,0)
 ;;=3^Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,28431,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,28431,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,28432,0)
 ;;=D68.318^^80^1224^23
 ;;^UTILITY(U,$J,358.3,28432,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28432,1,3,0)
 ;;=3^Hemorrhagic Disorder d/t Intrns Circ Anticoag/Antibodies/Inhibitors
 ;;^UTILITY(U,$J,358.3,28432,1,4,0)
 ;;=4^D68.318
 ;;^UTILITY(U,$J,358.3,28432,2)
 ;;=^340504
 ;;^UTILITY(U,$J,358.3,28433,0)
 ;;=D50.9^^80^1224^26
 ;;^UTILITY(U,$J,358.3,28433,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28433,1,3,0)
 ;;=3^Iron Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,28433,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,28433,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,28434,0)
 ;;=D64.81^^80^1224^2
 ;;^UTILITY(U,$J,358.3,28434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28434,1,3,0)
 ;;=3^Anemia d/t Antineoplastic Chemotherapy
 ;;^UTILITY(U,$J,358.3,28434,1,4,0)
 ;;=4^D64.81
 ;;^UTILITY(U,$J,358.3,28434,2)
 ;;=^5002349
 ;;^UTILITY(U,$J,358.3,28435,0)
 ;;=D63.1^^80^1224^4
 ;;^UTILITY(U,$J,358.3,28435,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28435,1,3,0)
 ;;=3^Anemia in Chronic Kidney Disease
 ;;^UTILITY(U,$J,358.3,28435,1,4,0)
 ;;=4^D63.1
 ;;^UTILITY(U,$J,358.3,28435,2)
 ;;=^332908
 ;;^UTILITY(U,$J,358.3,28436,0)
 ;;=D62.^^80^1224^1
 ;;^UTILITY(U,$J,358.3,28436,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28436,1,3,0)
 ;;=3^Acute Blood Loss Anemia
 ;;^UTILITY(U,$J,358.3,28436,1,4,0)
 ;;=4^D62.
 ;;^UTILITY(U,$J,358.3,28436,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,28437,0)
 ;;=D51.9^^80^1224^32
 ;;^UTILITY(U,$J,358.3,28437,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28437,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,28437,1,4,0)
 ;;=4^D51.9
 ;;^UTILITY(U,$J,358.3,28437,2)
 ;;=^5002289
 ;;^UTILITY(U,$J,358.3,28438,0)
 ;;=D51.3^^80^1224^31
 ;;^UTILITY(U,$J,358.3,28438,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28438,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Dietary
 ;;^UTILITY(U,$J,358.3,28438,1,4,0)
 ;;=4^D51.3
 ;;^UTILITY(U,$J,358.3,28438,2)
 ;;=^5002287
 ;;^UTILITY(U,$J,358.3,28439,0)
 ;;=D51.0^^80^1224^28
 ;;^UTILITY(U,$J,358.3,28439,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28439,1,3,0)
 ;;=3^Pernicious Anemia
 ;;^UTILITY(U,$J,358.3,28439,1,4,0)
 ;;=4^D51.0
 ;;^UTILITY(U,$J,358.3,28439,2)
 ;;=^5002284
 ;;^UTILITY(U,$J,358.3,28440,0)
 ;;=D50.0^^80^1224^3
 ;;^UTILITY(U,$J,358.3,28440,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28440,1,3,0)
 ;;=3^Anemia d/t Blood Loss (Chronic)
 ;;^UTILITY(U,$J,358.3,28440,1,4,0)
 ;;=4^D50.0
 ;;^UTILITY(U,$J,358.3,28440,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,28441,0)
 ;;=E11.21^^80^1224^18
 ;;^UTILITY(U,$J,358.3,28441,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28441,1,3,0)
 ;;=3^DM Type 2 w/ Nephropathy
 ;;^UTILITY(U,$J,358.3,28441,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,28441,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,28442,0)
 ;;=E11.22^^80^1224^8
 ;;^UTILITY(U,$J,358.3,28442,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28442,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic CKD
 ;;^UTILITY(U,$J,358.3,28442,1,4,0)
 ;;=4^E11.22
 ;;^UTILITY(U,$J,358.3,28442,2)
 ;;=^5002630
 ;;^UTILITY(U,$J,358.3,28443,0)
 ;;=E11.29^^80^1224^19
 ;;^UTILITY(U,$J,358.3,28443,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28443,1,3,0)
 ;;=3^DM Type 2 w/ Other Diabetic Kidney Complication
 ;;^UTILITY(U,$J,358.3,28443,1,4,0)
 ;;=4^E11.29
 ;;^UTILITY(U,$J,358.3,28443,2)
 ;;=^5002631
 ;;^UTILITY(U,$J,358.3,28444,0)
 ;;=E11.311^^80^1224^20
 ;;^UTILITY(U,$J,358.3,28444,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28444,1,3,0)
 ;;=3^DM Type 2 w/ Unspec Diabetic Retinopathy w/ Macular edema
 ;;^UTILITY(U,$J,358.3,28444,1,4,0)
 ;;=4^E11.311
 ;;^UTILITY(U,$J,358.3,28444,2)
 ;;=^5002632
 ;;^UTILITY(U,$J,358.3,28445,0)
 ;;=E11.319^^80^1224^21
 ;;^UTILITY(U,$J,358.3,28445,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28445,1,3,0)
 ;;=3^DM Type 2 w/ Unspec Diabetic Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,28445,1,4,0)
 ;;=4^E11.319
 ;;^UTILITY(U,$J,358.3,28445,2)
 ;;=^5002633
 ;;^UTILITY(U,$J,358.3,28446,0)
 ;;=E11.40^^80^1224^10
 ;;^UTILITY(U,$J,358.3,28446,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28446,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Neuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,28446,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,28446,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,28447,0)
 ;;=E11.41^^80^1224^9
 ;;^UTILITY(U,$J,358.3,28447,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28447,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Mononeuropathy
 ;;^UTILITY(U,$J,358.3,28447,1,4,0)
 ;;=4^E11.41
 ;;^UTILITY(U,$J,358.3,28447,2)
 ;;=^5002645
 ;;^UTILITY(U,$J,358.3,28448,0)
 ;;=E11.42^^80^1224^13
 ;;^UTILITY(U,$J,358.3,28448,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28448,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,28448,1,4,0)
 ;;=4^E11.42
 ;;^UTILITY(U,$J,358.3,28448,2)
 ;;=^5002646
 ;;^UTILITY(U,$J,358.3,28449,0)
 ;;=E11.43^^80^1224^7
